Unibest

Pharmaceutical intermediates

Febuxostat Intermediates

2 pharmaceutical intermediates for Febuxostat. Indication: Hyperuricemia; Gout.

Submit a ProjectAll intermediates

About Febuxostat

Originator
Teijin Limited
Indication
Hyperuricemia; Gout
Approved Date
02/13/2009
DS/DP
09/08/2031

Available intermediates

2 intermediates currently listed for Febuxostat. Request specifications, documentation or a quotation for any item below.

Febuxostat intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate161798-01-2//
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate161797-99-5//

Other programs under F

Fexuprazan HClFezolinetantFilgotinib MaleateFinerenoneFluralanerFostamatinib disodium hexahydrateFruquintinibFutibatinib

Building toward Febuxostat?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →